IL13 and Alzheimer disease: IL-13 plays a central role in AD pathogenesis, acting as a critical cytokine in the downstream cascade that results in skin barrier dysfunction and Th2 immune polarization, making it a logical therapeutic target for novel biologic therapies, and its blockade has demonstrated efficacy in reducing disease severity while preserving long-term tolerability.